<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496878/" ref="ordinalpos=2742&amp;ncbi_uid=4370678&amp;link_uid=PMC3496878" image-link="/pmc/articles/PMC3496878/figure/F5/" class="imagepopup">Figure 5.  From: <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">pathway</span>/molecular targets and new targeted agents under development in hepatocellular carcinoma. </a></div><br /><div class="p4l_captionBody">Mammalian target of rapamycin/hypoxia-inducible factor-1/vascular endothelial growth factor signaling pathway in angiogenesis in solid cancer. HIF: Hypoxia-inducible factor; VEGF: Vascular endothelial growth factor; mTOR: Mammalian target of rapamycin; FKBP12: FK506-binding protein 12.</div></div>